Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2013 08:30 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Host ADHD Seminar in New York City on August 6, 2013

TEL AVIV, Israel, July 30, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company primarily focused on the development and commercialization of its proprietary...
July 30, 2013 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. Appoints Dr. Jonathan Rubin as Chief Medical Officer

TEL AVIV, Israel, July 30, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company primarily focused on the development and commercialization of its proprietary...
July 24, 2013 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Provide Second Quarter 2013 Financials and Business Update on August 6th

TEL AVIV, Israel, July 24, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company primarily focused on the development and commercialization of its proprietary...
June 24, 2013 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. Announces U.S. Patent Issuance

--U.S. Patent #8,476,304 Covering Modified Release Metadoxine --Patent Effective Through July 3, 2032 TEL AVIV, Israel, June 24, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an...
June 03, 2013 08:30 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Ring the NASDAQ Stock Market Opening Bell on Thursday, June 6th

TEL AVIV, Israel, June 3, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug,...
May 28, 2013 11:45 ET | Source: Alcobra Ltd.

Alcobra Ltd. Announces Closing of Initial Public Offering

NEW YORK, May 28, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug, MG01CI,...
May 28, 2013 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Present at Upcoming Investor Conferences

TEL AVIV, Israel, May 28, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), today announced that it will be presenting at the Jefferies 2013 Global Healthcare Conference and at the ILSI-Biomed 2013...
May 21, 2013 20:34 ET | Source: Alcobra Ltd.

Alcobra Ltd. Prices Initial Public Offering of 3,125,000 Ordinary Shares

NEW YORK, May 21, 2013 (GLOBE NEWSWIRE) -- Alcobra Ltd., an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug, MG01CI, to treat...